Administration of transdermal nicotine improves cognitive performance in patients with mild cognitive impairment (MCI), according to the results of a pilot study (Newhouse et al. Neurology 2012;78:91-101).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
